Clinical Trials in Massachusetts

Showing 1781-1800 of 8,511 trials

COmmuNity-engaged SimULation Training for Blood Pressure Control

NCT03375918

The goal of CONSULT-BP is to train early-stage healthcare providers, including residents and nurse practitioner (NP) students, to mitigate providers' bias, improve communication skills, and enhance providers' ability to develop authentic and meaningful therapeutic alliances with patients. The study setting is an academic safety net hospital that serves a large non-White and poor population. The Investigators hypothesize that patients' outcomes (blood pressure levels) will be lower after the training intervention compared with before training (control) periods.

Hypertension

University of Massachusetts, Worcester118 participantsStarted Aug 2018

Barre, Massachusetts, United States • Uxbridge, Massachusetts, United States • Worcester, Massachusetts, United States +1 more locations

RECRUITINGPhase 214 miles

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

NCT06456593

This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared to placebo as induction and maintenance therapy in subjects with moderately to severely active CD after inadequate response (no response, loss of response, or intolerance) to conventional therapies and/or advanced therapies. The primary objective for the 48-Week Extension Phase is to evaluate the safety and tolerability of obefazimod compared with placebo in subjects who are enrolled in the Extension Phase.

Moderately to Severely Active Crohn Disease

Abivax S.A.212 participantsStarted Oct 2024

Fairhope, Alabama, United States • Scottsdale, Arizona, United States • Sun City, Arizona, United States +146 more locations

COmmuNity-engaged SimULation Training for Blood Pressure Control

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Find Trials by Condition in Massachusetts

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response

Mechanisms of Open and Hidden Placebo in Stroke Recovery

Menstrual-phase-dependent Differences in Response to Sleep Loss

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

A Study of Auxora in Patients With Severe COVID-19 Pneumonia

Vertical Soft Tissue Augmentation With CTG vs ADM

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum Production

Boston Birth Cohort Study

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs